Professor Alvaro Cruz from Brazil, member of the GINA board of directors and GINA dissemination and implementation committee with 30 years’ experience caring for patients with asthma, examines the assessment of asthma control and identification of patients at risk.
Recent Posts
- Usability of mepolizumab single-use prefilled syringe for patient self-administration
- EAACI Guidelines for the Use of Biologic Therapies in Severe Asthma
- The disease burden in patients with respiratory allergies induced by house dust mites: a year-long observational survey in three European countries
- The role of NTHi colonization and infection in the pathogenesis of neutrophilic asthma
- Therapeutic Differences Among Inhaled Corticosteroids Used to Treat Asthma